Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuba İlgar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMC Infectious Diseases|February 21, 2026
Risk factors for blood culture contamination in a tertiary hospital: a one-year retrospective analysisTuba İlgar, Aybegüm Özşahin
Microbial Drug Resistance (Larchmont, N.Y.)|March 14, 2026
Impact of Antimicrobial Resistance on Outcomes in Biliary Tract Infections: A Retrospective Study from a Tertiary Care CenterAybegüm Özşahin, Tuba İlgar, Zehra Zeynep Keklikkıran
Journal of Infection in Developing Countries|July 3, 2025
HBeAg clearance in chronic Hepatitis B: is it predictable?Tuba İlgar, Aybegüm Özşahin, Sudem Mahmutoğlu Çolak, et al.
Mikrobiyoloji Bulteni|March 12, 2017
[Cutaneous larva migrans in Turkey: an imported case report]Meliha Çağla Sönmezer, Şebnem Erdinç, Necla Tülek, et al.
Turkish Journal of Medical Sciences|September 19, 2024
The sharp edge of immunosuppressive treatments: infectionsAybegüm Özşahin, Tuba Ilgar, Sudem Mahmutoğlu Çolak, et al.
Life (Basel, Switzerland)|March 27, 2025
Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease PrognosisSudem Mahmutoğlu Çolak, Tuba İlgar, İlkay Bahçeci, et al.
BMC Infectious Diseases|October 22, 2025
Epidemiology of ventilator associated events in intubated patients: a multicenter observational studyEsma Eryılmaz Eren, Duygu Mert, Fatma Eser, et al.
Scientific Reports|May 30, 2026
Missed opportunities for HIV testing in hospitalised adults in türkiye: ındicator conditions and testing coverage in a national multicentre point-prevalence survey (HIV-ICs-TR)Yeliz Çiçek, Mustafa Kemal Çelen, Hüsnü Pullukçu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMC Infectious Diseases|February 21, 2026
Risk factors for blood culture contamination in a tertiary hospital: a one-year retrospective analysisTuba İlgar, Aybegüm Özşahin
Microbial Drug Resistance (Larchmont, N.Y.)|March 14, 2026
Impact of Antimicrobial Resistance on Outcomes in Biliary Tract Infections: A Retrospective Study from a Tertiary Care CenterAybegüm Özşahin, Tuba İlgar, Zehra Zeynep Keklikkıran
Journal of Infection in Developing Countries|July 3, 2025
HBeAg clearance in chronic Hepatitis B: is it predictable?Tuba İlgar, Aybegüm Özşahin, Sudem Mahmutoğlu Çolak, et al.
Mikrobiyoloji Bulteni|March 12, 2017
[Cutaneous larva migrans in Turkey: an imported case report]Meliha Çağla Sönmezer, Şebnem Erdinç, Necla Tülek, et al.
Turkish Journal of Medical Sciences|September 19, 2024
The sharp edge of immunosuppressive treatments: infectionsAybegüm Özşahin, Tuba Ilgar, Sudem Mahmutoğlu Çolak, et al.
Life (Basel, Switzerland)|March 27, 2025
Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease PrognosisSudem Mahmutoğlu Çolak, Tuba İlgar, İlkay Bahçeci, et al.
BMC Infectious Diseases|October 22, 2025
Epidemiology of ventilator associated events in intubated patients: a multicenter observational studyEsma Eryılmaz Eren, Duygu Mert, Fatma Eser, et al.
Scientific Reports|May 30, 2026
Missed opportunities for HIV testing in hospitalised adults in türkiye: ındicator conditions and testing coverage in a national multicentre point-prevalence survey (HIV-ICs-TR)Yeliz Çiçek, Mustafa Kemal Çelen, Hüsnü Pullukçu, et al.
Pageof 1